跳至主要内容
临床试验/JPRN-UMIN000040366
JPRN-UMIN000040366已完成未知

A prospective observational study of screening for MSI status in unresectable advanced gastric cancer: WJOG13320GPS - An observational study evaluating MSI status in unresectable advanced gastric cancer

West Japan Oncology Group0 个研究点目标入组 1,000 人开始时间: 2020年5月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Having concomitant active malignancies. 2)Requiring systemic corticosteroid or immunosuppressant. 3)History of prior anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CD137, anti-CTLA-4 antibody, or any other antibody which specifically targets T-cell co-stimulation or checkpoint pathways. 4)Inappropriate judged by the investigators.

研究者

相似试验